Short-Term Effects of Radial Extracorporeal Shock Wave Therapy in Addition to Physiotherapy on Spasticity, Walking Performance, and Quality of Life in Chronic Stroke: A Sham-Controlled Randomized Trial
NEUROREHABILITATION, cilt.0, sa.0, ss.1-10, 2026 (Hakemli Dergi)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 0 Sayı: 0
- Basım Tarihi: 2026
- Doi Numarası: 10.1177/10538135261486875
- Dergi Adı: NEUROREHABILITATION
- Sayfa Sayıları: ss.1-10
- İstanbul Medipol Üniversitesi Adresli: Evet
Özet
Abstract
Introduction: This study evaluated the short-term effects of adding a 4-week radial extracorporeal shock wave therapy
(rESWT) program to standardized physiotherapy on spasticity, walking performance, lower-extremity motor function,
and health-related quality of life in chronic stroke patients with plantar exor spasticity.
Methods: In this prospective, single-blind, sham-controlled trial, 85 chronic stroke survivors were randomized to active
rESWT (n= 43; 0.10–0.20 mJ/mm2, 4000–6000 pulses/session, 3 sessions/week) plus physiotherapy or sham rESWT plus
physiotherapy for 4 weeks. Outcomes were assessed at baseline and Week 4. The primary outcome was the Modi ed
Ashworth Scale (MAS). Secondary outcomes included the 10-Meter Walk Test (10MWT), Timed Up and Go (TUG)
test, 6-Minute Walk Test (6MWT), Fugl-Meyer Assessment–Lower Extremity (FMA-LE), and Stroke-Speci c Quality of
Life (SS-QOL) scale. Between-group treatment effects were estimated with baseline-adjusted analysis of covariance
and are reported with 95% con dence intervals.
Results: Adjusted mean differences favored the rESWT group for MAS (−0.56; 95% CI−0.77 to−0.35), 10MWT
(−1.41 s;−1.87 to−0.96), TUG (−2.46 s;−3.19 to−1.74), FMA-LE (4.42; 3.62 to 5.23), and SS-QOL (11.73; 9.15 to
14.31), all p < 0.001. Median MAS decreased from 2 to 1 in the rESWT group versus no change in controls. The
6MWT did not differ signi cantly between groups (−6.26 m;−15.27 to 2.74). No adverse events occurred.
Conclusions: Adding rESWT to physiotherapy produced short-term improvements in spasticity, walking, functional
mobility, motor function, and quality of life. Long-term ef cacy and safety require further study.
Trial Registration: ClinicalTrials.gov Identi er: “This eld has been blinded”
.
Keywords
extracorporeal shock wave therapy, spasticity, stroke rehabilitation, gait, quality of life